Patents Examined by Eric J Messersmith
  • Patent number: 10376216
    Abstract: Device for contactless monitoring of a patient's vital signs in the form of a measuring mat comprising at least one measuring element. The measuring element comprises a piezoelectric sensor with a first and a second conductive electrode and a piezoelectric element. Near the piezoelectric sensor is a third conductive electrode. The exertion of a mechanical force on the cover of the measuring element results in a change in the distance between at least one of the electrodes of the piezoelectric sensor and the third conductive electrode. This change in distance is expressed as a difference in the detected parameter corresponding to a change in the patient's vital signs.
    Type: Grant
    Filed: October 8, 2014
    Date of Patent: August 13, 2019
    Assignee: LINET SPOL. S R.O.
    Inventors: Vladimir Kolar, Libor Seidl
  • Patent number: 10369282
    Abstract: A medical device includes an antenna external to a case, package, or encapsulant for the electronic systems of the medical device. In one embodiment, a diabetes infusion pump is enclosed within a metal case, the pump including a processor and a communication module for wireless communications. An antenna is disposed in the delivery tubing of the pump outside the case with an antenna feed interconnecting the external antenna with the internal communication module. In another aspect, a thin film antenna is formed on the outer surface of the case in which a physiological parameter sensor, such as a glucose sensor, is enclosed. Multiple antennas may be used for communications on different frequencies.
    Type: Grant
    Filed: October 6, 2015
    Date of Patent: August 6, 2019
    Assignee: ABBOTT DIABETES CARE INC.
    Inventors: Nathan C. Crouther, Marc B. Taub, Lei He
  • Patent number: 10362946
    Abstract: A method and apparatus for monitoring a cardiovascular pressure signal in a medical device that includes determining whether the sensed pressure signal is greater than a first pressure threshold, determining a first metric of the pressure signal in response to the sensed pressure signal being greater than the first pressure threshold, determining whether the sensed pressure signal is greater than a second pressure threshold not equal to the first pressure threshold, determining a second metric of the pressure signal in response to the sensed pressure signal being greater than the first pressure threshold, and determining at least one of a systolic pressure or a diastolic pressure, wherein the at least one of a systolic pressure or a diastolic pressure is determined based on the first metric in response to the pressure signal not being greater than the second threshold, and based on the second metric in response to the pressure signal being greater than the second threshold.
    Type: Grant
    Filed: April 18, 2016
    Date of Patent: July 30, 2019
    Assignee: Medtronic, Inc.
    Inventor: Saul E. Greenhut
  • Patent number: 10362973
    Abstract: Systems and methods for analyte monitoring, particularly systems and methods for monitoring and managing life of a battery in an analyte sensor system worn by a user, are provided.
    Type: Grant
    Filed: December 18, 2015
    Date of Patent: July 30, 2019
    Assignee: DexCom, Inc.
    Inventors: Jose Hector Hernandez-Rosas, Mark Dervaes, Peter C. Simpson, Apurv Ullas Kamath, Tom Miller, Shawn Larvenz, Stephen J. Vanslyke
  • Patent number: 10362999
    Abstract: Gated physiological monitoring systems and methods are described that utilize a photoplethysmogram (PPG) monitoring device and another (different) physiological monitoring device, where the PPG monitoring device is operated based on timing information obtained from the other physiological monitoring device. In some implementations, control circuitry can be configured to operate the PPG monitoring device based on timing information from a physiological waveform detected by the physiological monitoring device. For example, the control circuitry can operate the PPG monitoring device to capture one or more selected portions of a measured PPG waveform that can then be used to estimate the full PPG waveform or portions of interest.
    Type: Grant
    Filed: October 24, 2016
    Date of Patent: July 30, 2019
    Assignee: MAXIM INTEGRATED PRODUCTS, INC.
    Inventors: Matthew Z. Straayer, Joohyun Seo
  • Patent number: 10357207
    Abstract: A device for generating alerts for Hypo and Hyperglycemia Prevention from Continuous Glucose Monitoring (CGM) determines a dynamic risk based on both information of glucose level and a trend obtainable from a CGM signals. The device includes a display whose color depends on the DR (for example, red for high DR, green for low risk). When DR exceeds a certain threshold, alerts are generated to suggest the patient to pay attention to the current glucose reading and to its trend, both of which are shown on the display in numbers and symbols (e.g. an arrow with different slope or color).
    Type: Grant
    Filed: August 17, 2016
    Date of Patent: July 23, 2019
    Assignee: DexCom, Inc.
    Inventors: Giovanni Sparacino, Claudio Cobelli, Stefania Guerra, Andrea Facchinetti, Michele Schiavon
  • Patent number: 10357164
    Abstract: A system for measuring blood pressure of a user that comprises an ElectroCardioGram (ECG) circuit with at least two ECG electrodes configured to obtain an electrical activity of a heart of the user by measuring the electrical signals detected at the at least two ECG electrodes as an electrocardiogram waveform, and a pulse oximeter circuit configured to obtain a pulse waveform corresponding to a blood flow on user's vessels. The system further comprises a processor that is in electrical contact with the electrocardiogram circuit and the pulse oximeter circuit. The processor is configured to simultaneously analyze the electrocardiogram waveform and the pulse waveform. The processor is further configured to identify a “Zero Voltage Crossing” point on the electrocardiogram waveform and to determine time delays from this point to respective different determined points of the pulse waveform; and to use the time delays to compute the blood pressure values.
    Type: Grant
    Filed: April 22, 2015
    Date of Patent: July 23, 2019
    Assignee: ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE (EPFL)
    Inventors: Alair Dias Júnior, Srinivasan Murali, Francisco Javier Rincon Vallejos, David Atienza Alonso
  • Patent number: 10349873
    Abstract: Systems and methods of use for continuous analyte measurement of a host's vascular system are provided. In some embodiments, a continuous glucose measurement system includes a vascular access device, a sensor and sensor electronics, the system being configured for insertion into communication with a host's circulatory system.
    Type: Grant
    Filed: April 27, 2016
    Date of Patent: July 16, 2019
    Assignee: DexCom, Inc.
    Inventors: Apurv Ullas Kamath, Jacob S. Leach, Ying Li, Daiting Rong, Sean Saint, Peter C. Simpson, Mark C. Brister
  • Patent number: 10349839
    Abstract: An implantable pressure sensor device (100) has a housing (10) which is at least partially made of a pressure transmitting membrane (20), and which includes one or more regions which can reversibly deform while maintaining the surface area of the membrane (20) when the internal volume of the housing (10) is changed. The housing (10) has a non-circular cross-section which can deform to a more circular shape when pressure in the internal volume increases. An inner housing is preferably situated within the housing, with its exterior spaced from the interior of the housing, and has its inner volume in fluid communication with the space between the housing and inner housing.
    Type: Grant
    Filed: February 17, 2016
    Date of Patent: July 16, 2019
    Assignee: BIOTRONIK SE & CO.
    Inventors: Jens Philipp, Joachim Elsner, Sarah Biela, Alois Pfenniger, Andreas Bitzer, Henning Ebert, Olaf Skerl, Andre van Ooyen
  • Patent number: 10349883
    Abstract: Airway impedance of a subject using a respiratory treatment device can be measured, in accordance with one or more embodiments. A conduit is configured to communicate a flow of inhaled gas and a flow of exhaled gas to and from an airway of the subject using the respiratory treatment device. A first valve is disposed within the conduit and configured to affect the flow of exhaled gas. One or more sensors are disposed within the conduit and are configured to provide a signal conveying information associated with one or more characteristics of gas exhaled by the subject while the flow of exhaled gas is affected or unaffected by the first valve. An airway impedance monitoring module can be executed by a processor to determine an impedance metric of the airway of the subject based on the information conveyed by the signal provided by the one or more sensors.
    Type: Grant
    Filed: December 18, 2012
    Date of Patent: July 16, 2019
    Assignee: KONINKLIJKE PHILIPS N.V.
    Inventors: Alberto Fazzi, Teunis Johannes Vink, Dirk Erneset Von Hollen
  • Patent number: 10342472
    Abstract: The present invention relates to a system and method for assessing and training the quality of attentional awareness and control of an individual. The individual's attention is monitored using a neurophysiological system such as EEG while using a computer system and display that provides signals that allow the correlation of behavioral measures of attention with neurophysiological measures. The combination of those signals is a novel, accurate and reliable system for assessing any individual's true attention capabilities.
    Type: Grant
    Filed: April 4, 2016
    Date of Patent: July 9, 2019
    Assignee: Think-Now Inc.
    Inventor: Gregory V. Simpson
  • Patent number: 10342214
    Abstract: A device (1) to tag an animal is disclosed. The device comprises a female (20) including a case (21) with a thorough hole (22), a male (40) to be coupled to the female (20) and including a stem (41) with a tip portion (60); the female (20) includes tamperproof fastening means (23) adapted to block the tip portion (60) in the thorough hole (22) and wherein, after coupling the male (40) with the female (20), the hole (22) is closed by the tip (60), the tip becomes part of the female (20) and the stem (41) moves in the case (21).
    Type: Grant
    Filed: October 22, 2014
    Date of Patent: July 9, 2019
    Assignee: DATAMARS SA
    Inventors: Damien Pachoud, Julien Buros
  • Patent number: 10335066
    Abstract: An inserter assembly for continuous glucose monitoring with medication delivery capability where the assembly has a deployment button containing a needle deployment mechanism having a sharp held in a pre-release position, a housing body in which the deployment button is movably received within a top end of the housing body, the housing body having a sensor deployment assembly containing a lumen and a sensor disposed within the lumen and extending out of the lumen to a circuit board that is part of the sensor deployment assembly, the sensor deployment assembly matingly connected to the sharp where the sharp extends beyond the sensor deployment assembly and contains the sensor not fixedly attached to the sharp, and a sensor housing releasably received within a lower end of the housing body, the sharp extending into a sensor deployment assembly recess within the sensor housing and directly above a sensor opening in a bottom of the sensor housing.
    Type: Grant
    Filed: September 2, 2015
    Date of Patent: July 2, 2019
    Inventors: Thomas H. Peterson, Scott P. Cionek, Anthony Florindi, Julian I. Hart
  • Patent number: 10327676
    Abstract: A flexible, multi-layered device for automatically sensing sweat biomarkers, storing and transmitting sensed data via wireless network to a computing device having software applications operable thereon for receiving and analyzing the sensed data. The device is functional in extreme conditions, including extremely hot temperatures, extremely cold temperatures, high salinity, high altitude, extreme pHs, and/or extreme pressures.
    Type: Grant
    Filed: December 13, 2017
    Date of Patent: June 25, 2019
    Assignee: CORESYTE, INC.
    Inventors: Sten Adam Nyberg, Dalton Pont, Adam Pizer, John V. Chiochetti
  • Patent number: 10327677
    Abstract: Embodiments of the present disclosure relate to analyte determining methods and devices (e.g., electrochemical analyte monitoring systems) that have a sensing surface that includes two or more sensing elements disposed laterally to each other, where the sensing surface is on a working electrode of in vivo and/or in vitro analyte sensors, e.g., continuous and/or automatic in vivo monitoring using analyte sensors and/or test strips. Also provided are systems and methods of using the, for example electrochemical, analyte sensors in analyte monitoring.
    Type: Grant
    Filed: December 8, 2011
    Date of Patent: June 25, 2019
    Assignee: Abbott Diabetes Care Inc.
    Inventors: Udo Hoss, Phu Le, Yi Wang, Frank David Fujimoto, Suyue Qian, Lam Tran
  • Patent number: 10327644
    Abstract: A biochip device, or a system of biochips, providing diagnostic testing, sensing and therapeutic functionality useful in diagnosis and treatment of a variety of physiological maladies.
    Type: Grant
    Filed: March 14, 2016
    Date of Patent: June 25, 2019
    Assignee: International Business Machines Corporation
    Inventor: Eric V. Kline
  • Patent number: 10321866
    Abstract: Systems, methods and devices are disclosed for directing and focusing signals to the brain for neuromodulation and for directing and focusing signals or other energy from the brain for measurement, heat transfer and imaging. An aperture in the skull and/or a channel device implantable in the skull can be used to facilitate direction and focusing. Treatment and diagnosis of multiple neurological conditions may be facilitated with the disclosed systems, methods and devices.
    Type: Grant
    Filed: September 12, 2014
    Date of Patent: June 18, 2019
    Assignee: NeuroPace, Inc.
    Inventors: Benjamin D. Pless, Stephen T. Archer, Craig M. Baysinger, Barbara Gibb, Suresh Gurunathan, Bruce Kirkpatrick, Thomas K. Tcheng
  • Patent number: 10314517
    Abstract: A wearable respiration monitoring system and associated method that is configured to (i) determine three dimensional displacement of the spine of a subject with respect to the axial displacement of the subject's chest wall, (ii) process the three dimensional anatomical data, (iii) determine at least one respiration parameter associated with the monitored subject as a function of the three dimensional anatomical data, and (iv) generate at least one respiration parameter signal representing the respiration parameter.
    Type: Grant
    Filed: August 30, 2018
    Date of Patent: June 11, 2019
    Assignee: Medical Design Solutions, Inc.
    Inventor: Robert T Stone
  • Patent number: 10307110
    Abstract: Systems, devices, and methods for determining a user's lung capacity may employ a sound-producing breathing device and a recording device such as a microphone included in a user electronic device (e.g., smart phone or tablet computer). A user may inhale or exhale through the sound-producing breathing device, thereby producing a sound that is received by the microphone and communicated to a processor. The processor may analyze the received sound recording to determine one or more sound intensity values over, for example, the duration of the received sound and/or points in time within the sound recording. The sound intensity values may then be used to determine the user's lung capacity.
    Type: Grant
    Filed: August 20, 2018
    Date of Patent: June 4, 2019
    Assignee: Human Resolution Technologies, LLC
    Inventors: Gregory O'Keeffe, Brian Dutton, Mark Seelig, Debra Sarvis, Raymond Cha
  • Patent number: 10299733
    Abstract: Continuous Glucose Monitoring (CGM) devices provide glucose concentration measurements in the subcutaneous tissue with limited accuracy and precision. Therefore, CGM readings cannot be incorporated in a straightforward manner in outcome metrics of clinical trials e.g. aimed to assess new glycaemic-regulation therapies. To define those outcome metrics, frequent Blood Glucose (BG) reference measurements are still needed, with consequent relevant difficulties in outpatient settings. Here we propose a “retrofitting” algorithm that produces a quasi continuous time BG profile by simultaneously exploiting the high accuracy of available BG references (possibly very sparsely collected) and the high temporal resolution of CGM data (usually noisy and affected by significant bias).
    Type: Grant
    Filed: February 20, 2014
    Date of Patent: May 28, 2019
    Assignee: DexCom, Inc.
    Inventors: Claudio Cobelli, Simone Del Favero, Andrea Facchinetti, Giovanni Sparacino